Robotic surgery for thoracic cancer using the Medtronic Hugo™ system
Thoracic Surgery by the Medtronic Hugo™ Robotic System: A Prospective Single Centre Study
This study is testing if using the Medtronic Hugo™ robotic system for thoracic cancer surgery can improve outcomes for patients undergoing procedures like lung resections.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06669104 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the use of the Medtronic Hugo™ robotic system in performing thoracic surgeries for patients with thoracic cancer. The study focuses on the advantages of robotic-assisted surgery, such as enhanced precision and minimally invasive techniques, which can lead to better patient outcomes. Participants will undergo various thoracic surgical procedures, including mediastinal tumor resections and lung resections, utilizing the advanced capabilities of the robotic system. The study aims to gather data on the effectiveness and safety of this innovative surgical approach.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 80 with a body mass index under 35 who are suitable for minimally invasive surgery.
Not a fit: Patients with severe concomitant illnesses, untreated active infections, or those requiring emergency surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved surgical outcomes and recovery times for patients with thoracic cancer.
How similar studies have performed: Other studies have shown success with robotic-assisted surgeries in various fields, indicating a promising potential for this approach in thoracic surgery as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age between 18 - 80 years 2. Body mass index \<35 kg/m2 3. Suitable for minimally invasive surgery 4. Willingness to participate as demonstrated by giving informed consent Exclusion Criteria: 1. Contraindication to general anaesthesia 2. Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention 3. Untreated active infection 4. Non-correctable coagulopathy 5. Emergency surgery 6. Vulnerable population (e.g. mentally disabled, pregnancy)
Where this trial is running
Hong Kong
- Prince of Wales Hospital — Hong Kong, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Calvin Sze Hang Ng — Cuhk
- Study coordinator: Calvin Sze Hang Ng
- Email: calvinng@surgery.cuhk.edu.hk
- Phone: 85235052629
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.